TGFB1 and colorectal carcinoma: Taken together, these findings suggested that the transcriptomic profile of KRASmut is not only linked to CMS3-enrichement, a prominent metabolic adaptation in CRC at the pathway level, but also enables remodeling of immune TME via activation of the TGFβ signaling pathway to reduce pro-inflammatory cytokines and suppress immune infiltration.